Sero-prevalence of human immunodeficiency virus–hepatitis B virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis

Kafeero, Hussein Mukasa; Ndagire, Dorothy; Ocama, Ponsiano; Walusansa, Abdul; Sendagire, Hakim

doi:10.1186/s12985-020-01443-6

Virology Journal

Table 1 Characteristics of the eligible studies

From: Sero-prevalence of human immunodeficiency virus–hepatitis B virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis

First author, year	Country	Study design	Sampling technique	Sample	HBV/HIV co-infection	Diagnostic Method	QS
Andersson et al. [14]	South Africa	Cross-section	Purposive	3089	53	ELISA	8
Bafa et al. [27]	Ethiopia	Cross-section	Random	222	4	RDT	9
Chasela et al. [32]	Malawi	Cross-section	Entire	2048	103	ELISA	9
Desalegn et al. [28]	Ethiopia	Cross-section	Entire	202	1	EIA	6
Dionne-Odom et al. [60]	Cameroon	Cross-section	Consecutive	7069	205	RDT	9
Ezechi et al. [46]	Nigeria	Cross-section	Purposive	2391	101	ELISA	9
Ilboudo et al. [39]	Burkina Faso	Cross-section	Purposive	115	14	RDT	6
Mbaawuaga et al. [47]	Nigeria	Cross-section	Purposive	507	5	RDT	7
Mpody et al. [61]	DR Congo	Cross-section	Entire	1377	65	ELISA	8
Abwonga et al. [55]	Cameroon	Cross-section	Entire	301	5	RDT	7
Adesina et al. [48]	Nigeria	Cross-section	Entire	721	64	ELISA	7
Amsalu et al. [29]	Ethiopia	Cross-section	Purposive	475	10	RDT	8
Andreotti et al. [33]	Malawi	Cross-section	Entire	309	28	RDT	7
Bassey et al. [49]	Nigeria	Cross-section	Purposive	500	36	ELISA	8
Bayo et al. [37]	Uganda	Cross-section	Random	402	4	ELISA	7
Dabsu et al. [30]	Ethiopia	Cross-section	Convenient	421	1	RDT	8
Fomulu et al. [56]	Cameroon	Cross-section	Consecutive	959	7	ELISA	8
Frempong et al. [41]	Ghana	Cross-section	Consecutive	248	22	EIA	8
Helegbe et al. [42]	Ghana	Cross-section	Purposive	3127	1	VCIA	9
Ikeako et al. [50]	Nigeria	Retrospective	Entire	1239	3	ELISA	9
Kfutwah et al. [57]	Cameroon	Cross-section	Entire	650	28	RDT	8
Lar et al. [18]	Nigeria	Cross-section	Entire	135	16	ELISA	8
MacLean et al. [45]	Mali	Cross-section	Entire	3659	14	ELISA	8
Manyahi et al. [36]	Tanzania	Cross-section	Consecutive	249	7	ELISA	8
Mutagoma et al. [34]	Rwanda	Cross-section	Entire	13,121	20	ELISA	9
Noubiap et al. [58]	Cameroon	Cross-section	Consecutive	325	5	RDT	7
Ntiamoah et al. [43]	Ghana	Cross-section	Purposive	124	11	RDT	6
Ojiegbe et al. [51]	Nigeria	Cross-section	Purposive	300	3	ELISA	6
Pirillo et al. [35]	Rwanda	Cross-section	Entire	82	2	RDT	7
Pirillo et al. [35]	Uganda	Cross-section	Entire	164	8	ELISA	7
Rouet et al. [44]	Ivory cost	Retrospective	Entire	449	45	ELISA	8
Seremba et al. [38]	Uganda	Cross-section	Purposive	612	9	AAS	7
Simpore et al. [40]	Burkina Faso	Cross-section	Entire	336	24	AAS	7
Tanjong Re et al. [59]	Cameroon	Cross-section	Purposive	406	6	AAS	8
Thumbiran et al. [54]	South Africa	Cross-section	Entire	570	18	ELISA	6
Usanga et al. [52]	Nigeria	Cross-section	Purposive	562	5	ELISA	8
Ya’aba et al. [53]	Nigeria	Cross-section	Purposive	330	90	ELISA	7
Zenebe et al. [31]	Ethiopia	Cross-section	Random	318	4	RDT	9

VCIA vitros chemi luminescent immunoassay, AAS abbott ARCHITECT system, ELISA enzyme linked immuno assay, EIA enzyme immuno assay, RDT rapid diagnostic test, QS quality score

Back to article page

ISSN: 1743-422X

Contact us

Submission enquiries: journalsubmissions@springernature.com